Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,474
Active & Responsive
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
for
Metastatic Castrate Resistant Prostate Cancer,
Location: Seattle WA, Portland OR, Boise ID, West Los Angeles CA,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT04038502
Phase 2, Recruiting
Active & Responsive
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
for
Polycythemia Vera
Location: Seattle WA, Eugene OR, Salt Lake City UT, Redlands CA,
Sponsor: Italfarmaco
Sex: All
Age: 18+
Code: NCT06093672
Phase 3, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Seattle WA, Portland OR, Billings MT, Palo Alto CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase 3, Recruiting
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Tacoma WA, Puyallup WA, Concord CA, San Francisco CA,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Phase 4, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Pancreatic Cancer Detection Consortium
for
Pancreatic Cancer, Pancreatic Carcinoma,
Location: Tacoma WA, Monrovia CA, Phoenix AZ, Peoria IL,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06388967
Recruiting
Active & Responsive
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Puyallup WA, Kalispell MT, Meridian ID, Edmonton,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase 3, Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: Mercer Island WA, Seattle WA, Salt Lake City UT,
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & Responsive
Pediatric Normative Markerless Movement Analysis
for
Pediatric ALL, Adolescent
Location: Puyallup WA
Sponsor: MultiCare Health System Research Institute
Sex: All
Age: 3 - 25
Code: NCT06249880
Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Tacoma WA, New Westminster, Surrey, North Vancouver,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer